Dr. Maryam Fouladi, MD
Claim this profileNationwide Children's Hospital
Expert in Brain Tumor
Studies Diffuse Intrinsic Pontine Glioma
13 reported clinical trials
20 drugs studied
Area of expertise
1Brain Tumor
Global LeaderNTRK positive
IDH positive
H3 K27 positive
2Diffuse Intrinsic Pontine Glioma
NTRK positive
IDH positive
H3 K27 positive
Affiliated Hospitals
Clinical Trials Maryam Fouladi, MD is currently running
PEP-CMV Vaccine
for Pediatric Brain Tumor
This study will address the question of whether targeting CMV antigens with PEP-CMV can serve as a novel immunotherapeutic approach in pediatric patients with newly-diagnosed high-grade glioma (HGG) or diffuse intrinsic pontine glioma (DIPG) as well as recurrent medulloblastoma (MB). PEP-CMV is a vaccine mixture of a peptide referred to as Component A. Component A is a synthetic long peptide (SLP) of 26 amino acid residues from human pp65. The SLPs encode multiple potential class I, class II, and antibody epitopes across several haplotypes. Component A will be administered as a stable water:oil emulsion in Montanide ISA 51. Funding Source - FDA OOPD
Recruiting1 award Phase 2
Savolitinib
for Brain Tumors
This phase I trial studies the side effects and best dose of volitinib in treating patients with primary central nervous system (CNS) tumors that have come back (recurrent) or does not respond to treatment (refractory). Volitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting1 award Phase 1
More about Maryam Fouladi, MD
Clinical Trial Related1 year of experience running clinical trials · Led 13 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Maryam Fouladi, MD has experience with
- Temozolomide
- Olutasidenib
- Binimetinib
- Tocilizumab
- Larotrectinib
- Larotrectinib Surgical
Breakdown of trials Maryam Fouladi, MD has run
Brain Tumor
Diffuse Intrinsic Pontine Glioma
Glioblastoma
Astrocytoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maryam Fouladi, MD specialize in?
Maryam Fouladi, MD focuses on Brain Tumor and Diffuse Intrinsic Pontine Glioma. In particular, much of their work with Brain Tumor has involved NTRK positive patients, or patients who are IDH positive.
Is Maryam Fouladi, MD currently recruiting for clinical trials?
Yes, Maryam Fouladi, MD is currently recruiting for 7 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that Maryam Fouladi, MD has studied deeply?
Yes, Maryam Fouladi, MD has studied treatments such as Temozolomide, Olutasidenib, Binimetinib.
What is the best way to schedule an appointment with Maryam Fouladi, MD?
Apply for one of the trials that Maryam Fouladi, MD is conducting.
What is the office address of Maryam Fouladi, MD?
The office of Maryam Fouladi, MD is located at: Nationwide Children's Hospital, Columbus, Ohio 43235 United States. This is the address for their practice at the Nationwide Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.